Immix Biopharma (IMMX) Insider Trading & Ownership $2.24 +0.18 (+8.74%) Closing price 04:00 PM EasternExtended Trading$2.31 +0.07 (+3.12%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immix Biopharma (NASDAQ:IMMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage55.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$20.23KNumber OfInsiders Selling(Last 12 Months)0 Get IMMX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMMX Insider Buying and Selling by Quarter Immix Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/17/2025Ilya M RachmanCEOBuy2,500$2.02$5,050.00 9/16/2025Gabriel S MorrisCFOBuy2,600$1.97$5,122.00 6/18/2025Gabriel S MorrisCFOBuy2,225$2.28$5,073.00 6/18/2025Ilya M RachmanCEOBuy2,178$2.29$4,987.62 (Data available from 1/1/2013 forward) IMMX Insider Trading Activity - Frequently Asked Questions Who is on Immix Biopharma's Insider Roster? The list of insiders at Immix Biopharma includes Carey Ng, Gabriel S Morris, Helen C Adams, Ilya M Rachman, Jason Hsu, Magda Marquet, and Melissa Jane Buchan. Learn more on insiders at IMMX. What percentage of Immix Biopharma stock is owned by insiders? 55.40% of Immix Biopharma stock is owned by insiders. Learn more on IMMX's insider holdings. Which Immix Biopharma insiders have been buying company stock? The following insiders have purchased IMMX shares in the last 24 months: Carey Ng ($18,600.00), Gabriel S Morris ($31,503.00), Ilya M Rachman ($25,250.62), and Jason Hsu ($286,294.00). How much insider buying is happening at Immix Biopharma? Insiders have purchased a total of 101,903 IMMX shares in the last 24 months for a total of $361,647.62 bought. Immix Biopharma Key ExecutivesDr. Ilya Rachman M.B.A. (Age 51)M.D., MBA, Ph.D., Co-Founder, CEO & Chairman Compensation: $637.5kMr. Gabriel Morris B.A. (Age 37)CFO & Director Compensation: $637.5kMr. Sean Senn J.D.M.B.A., M.Sc., MBA, MSc, Co-FounderDr. Vladimir P. Torchilin D.Sc. (Age 77)MSE, Ph.D., Scientific Co-Founder Mr. Ben H. Lyon J.D.Executive VP & General CounselDr. Graham Ross FFPM (Age 64)M.D., Chief Medical Officer & Head of Clinical Development Mr. Nandan Oza B.S. (Age 62)Head of Chemistry, Manufacturing & Control Dr. David MarksChief Medical Officer of Cell TherapyMr. Gerhard BauerHead of Cell Thearpy Manufacturing More Insider Trading Tools from MarketBeat Related Companies Heron Therapeutics Insider Buying Atea Pharmaceuticals Insider Buying Sagimet Biosciences Insider Buying Enanta Pharmaceuticals Insider Buying Entrada Therapeutics Insider Buying Black Diamond Therapeutics Insider Buying Cabaletta Bio Insider Buying Caribou Biosciences Insider Buying Tonix Pharmaceuticals Insider Buying Aclaris Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges This page (NASDAQ:IMMX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
